Activity Dates: 01/09/2018 - 12/31/2019
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
This self-study course is designed to assist the learner in developing and maintaining contemporary knowledge and skills in the pharmacotherapy management of sleep disorders. Content includes a comprehensive outline focused on etiology, risk factors, pathophysiology and treatment of sleep disorders. Specific focus is placed on identifying common signs and symptoms based on DSM-5 criteria, resolving drug therapy problems and developing an appropriate monitoring plan.
You will proceed through the following steps to satisfactorily complete this course:
This course is provided online at cpnp.org and is available to participants through the course expiration date. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at https://aapp.org/mycpnp/transcript/acpe.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Megan Maroney, PharmD, BCPP
Clinical Associate Professor
Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey
Long Branch, NJ
No Relevant Financial Relationships to Disclose
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Janssen Connect (division of Janssen Pharmaceuticals); Speakers Bureau: Otsuka-Lundbeck EXCEL Speaker's Bureau
Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: antihistamines, trazodone, mirtazapine, amitriptyline, gabapentin, tiagabine, quetiapine, olanzapine, melatonin, tryptophan, german chamomile, kava kava and valerian for insomnia, antidepressants and stimulants for narcolepsy and obstructive sleep apnea, methylxanthenes, estrogen, nasal decongestants, mirtazapine, paroxetine, xylometazoline, pantoprazole, zolpidem, eszopiclone and acetazolamide for obstructive sleep apnea, melatonin and vitamin B12 for circadian rhythm disorders, carbidopa/levodopa, cabergoline, pregabalin, iron, clonazepam, gabapentin, carbamazepine, clonidine, lisuride, amantadine, valproic acid, oxcarbazepine, rifaximin, botulinum neurotoxin, bupropion, selenium, transcranial magnetic stimulation, near-infrared spectroscopy, valerian, vitamin C and E and opioids for restless legs syndrome
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.5 contact hours of knowledge-based continuing education credit from CPNP approved programming.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
2018-2019 Editorial Board
Benjamin Chavez, PharmD, BCPP, BCACP Associate Professor University of Colorado Skaggs School of Pharmacy Aurora, CO External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: ACSAP Book Chapter Author Non-Financial Interests: Board of Directors of CPNP |
Megan J. Ehret, PharmD, MS, BCPP |
Clayton D. English, PharmD, BCPP, BCPS |
Rex S. Lott, PharmD, BCPP Professor Emeritus of Pharmacy Practice Idaho State University - College of Pharmacy Meridian, ID No Relevant Financial Relationships to Disclose |
Carol A. Ott, PharmD, BCPP |
Chris Paxos, PharmD, BCPP, BCPS, BCGP Pharmacotherapy Specialist Cleveland Clinic Akron General Akron, OH No Relevant Financial Relationships to Disclose |
Stephanie V. Phan, PharmD, BCPP |
Todd J. Woodard, PharmD, BCPP, BCPS, BCGP, CPE Manager, Clinical Pharmacy Services Peach State Health Plan Atlanta, GA Adjunct Clinical Assistant Professor of Pharmacy Practice Philadelphia College of Osteopathic Medicine School of Pharmacy Suwanee, GA No Relevant Financial Relationships to Disclose |
Jennifer L. Zacher, PharmD, BCPP Assistant Chief Consultant VA Pharmacy Benefits Management Service Hines, IL No Relevant Financial Relationships to Disclose |
2018-2019 Peer Reviewers
Katie Adams, PharmD, BCPP, BCPS |
Cassandra Clement, PharmD, BCPS, BCPP Mental Health Clinical Pharmacy Specialist Orlando VA Medical Center Orlando, FL |
Nicole Cupples, PharmD, BCPP, BCPS Clinical Pharmacist South Texas Veterans Healthcare System San Antonio, TX No Relevant Financial Relationships to Disclose |
Kathryn DeMent, BCPS, BCPP Clinical Pharmacist Eastern Kansas VAMC Topeka, KS No Relevant Financial Relationships to Disclose |
Lauren Diefenderfer, PharmD, BCPP Clinical Pharmacist Center for Behavioral Medicine Kansas City, MO |
Amie Jo Digatono, PharmD, BCPP Pharmacist Mercy Hospital - Unity Campus Fridley, MN No Relevant Financial Relationships to Disclose |
Courtney Eatmon, PharmD, BCPP Clinical Pharmacist Veterans Affairs Medical Center Lexington, KY External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: BPS specialty council as a non-specialist member of pharmacotherapy board |
Jessica Goren, PharmD, BCPP |
Tonya Gross, PharmD, BCPP Clinical Pharmacist Avera Behavioral Health Center Sioux Falls , SD No Relevant Financial Relationships to Disclose |
Beth Hall, PharmD, BCPP Director of Pharmacy Fulton State Hospital Fulton, MO |
Jessica Ho, PharmD, BCPP, BCPS Clinical Pharmacy Specialist, Psychiatry Kaiser Permanente of the Mid-Atlantic States Burke, VA No Relevant Financial Relationships to Disclose |
Cherry Jackson, PharmD, BCPP, FASHP Professor of Pharmacy, Auburn University; Professor of Medicine, University of Alabama, Birmingham Auburn University Harrison School of Pharmacy, University of Alabama, Birmingham, School of Medicine Birmingham, AL Non-Financial Interests: CPNP, ASHP, AlSHP |
Ismar Karadzic, PharmD, BCPP Regional Director of Pharmacy Eastern Missouri Psychiatric Hospital System Regional Director of Pharmacy St. Louis, MO |
Katherine Koller, PharmD, BCPP Psychiatric Clinical Pharmacy Specialist Battle Creek VA Medical Center Battle Creek, MI |
Marketa Marvanova, PharmD, BCGP, BCPP, PhD |
Lindsey N. Miller, PharmD, BCPP |
Jason Noel, PharmD, BCPP Faculty University of Maryland Baltimore, MD No Relevant Financial Relationships to Disclose |
William Olsufka, PharmD, BCPP Assistant Professor Touro College of Pharmacy New York, NY No Relevant Financial Relationships to Disclose |
Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences School of Pharmacy Notre Dame of Maryland University Baltimore , MD Employment: Notre Dame of Maryland University School of Pharmacy |
Alyssa Peckham, PharmD, BCPP Assistant Professor of Pharmacy Practice Midwestern University Glendale, AZ |
Talia Puzantian, PharmD, BCPP Associate Professor Keck Graduate Institute Claremont, CA No Relevant Financial Relationships to Disclose |
Shannon Saldana, PharmD, MS, BCPP Pharmacy Clinical Specialist, Psychiatry Primary Children's Hospital Sandy, UT |
Thomas Smith, PharmD, BCPP Assistant Professor of Pharmacy Practice Manchester College of Pharmacy Fort Wayne, IN |
Gita Soltani, PharmD, BCCP, BCPS Clinical Pharmacist Florida State Hospital Chattahoochee, FL |
Katy Tomisser, PharmD, BCPP Director of Pharmacy Western State Hospital Pharmacy Lakewood, WA |
Gabriela Williams, PharmD, BCPS, BCPP Clinical Pharmacy Specialist, Psychiatry Eskenazi Health Indianapolis, IN |
All relevant relationships have been mitigated.
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.